641
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects

, , , , , , , , , , , , , & show all
Pages 542-551 | Received 07 Jan 2015, Accepted 19 Jul 2015, Published online: 31 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael Hughes & Ariane L Herrick. (2023) Diagnosis and management of systemic sclerosis-related calcinosis. Expert Review of Clinical Immunology 19:1, pages 45-54.
Read now
Christos Liaskos, Emmanouela Marou, Theodora Simopoulou, Maria Barmakoudi, Georgios Efthymiou, Thomas Scheper, Wolfgang Meyer, Dimitrios P. Bogdanos & Lazaros I. Sakkas. (2017) Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity 50:7, pages 414-421.
Read now

Articles from other publishers (23)

Carrie Richardson, Jamie Perin, Scott Zeger, Fredrick M Wigley, Laura K Hummers, Livia Casciola-Rosen, Antony Rosen & Ami A Shah. (2023) Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis. Rheumatology 62:11, pages 3636-3643.
Crossref
Sindhu R. Johnson & Ivan Foeldvari. (2023) Approach to Systemic Sclerosis Patient Assessment. Rheumatic Disease Clinics of North America 49:2, pages 193-210.
Crossref
Paul Breillat, Kuberaka Mariampillai, Paul Legendre, Pauline Martins, Bertrand Dunogue, Jean Luc Charuel, Makoto Miyara, Claire Goulvestre, Romain Paule, Helene Vanquaethem, Felix Ackermann, Olivier Benveniste, Hilario Nunes, Luc Mouthon, Yves Allenbach & Yurdagul Uzunhan. (2023) Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses. Rheumatology 62:4, pages 1467-1475.
Crossref
Paweł Żebryk, Piotr Przymuszała, Jan Krzysztof Nowak, Tomasz Piorunek, Tatiana Mularek-Kubzdela & Mariusz Puszczewicz. (2023) Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study. Journal of Clinical Medicine 12:2, pages 657.
Crossref
Youssef Abida, Hanene Benrhouma, Emna Farhat, Thouraya Ben Younes, Imen Habibi, Hedia Klaa, Alexandre Reymond, Ichraf Kraoua & Ilhem Ben Youssef-Turki. (2023) LGMDR1 with Prominent Limb–Joint Contractures and Inflammatory Changes Misdiagnosed as Scleromyositis with a Novel CAPN3 Mutation: A Case Report . US Neurology 19:1, pages 46.
Crossref
Ilaria Cavazzana, Tamara Vojinovic, Paolo Airo’, Micaela Fredi, Angela Ceribelli, Eleonora Pedretti, Maria Grazia Lazzaroni, Emirena Garrafa & Franco Franceschini. (2022) Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers. Clinical Reviews in Allergy & Immunology 64:3, pages 412-430.
Crossref
Antonia Valenzuela, Kathryn Stevens, Melody P. Chung, Tatiana S. Rodriguez-Reyna, Susanna Proudman, Murray Baron, Flavia V. Castelino, Vivien Hsu, Lorraine Green, Francesco Del Galdo, Shufeng Li, David Fiorentino & Lorinda Chung. (2022) Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism 53, pages 151980.
Crossref
Karen Kruzer, Roberta Goncalves Marangoni, Ilana Heckler, Aya Elhage, John Varga, Monique Hinchcliff, Mary Carns, Kathleen Aren, Amy Wielgosz, Marc Nuzzo, Iswariya Venkataraman & Benjamin Korman. (2022) Clinical and Autoantibody Associations in Antinuclear Antibody–Positive Systemic Sclerosis Lacking Prototypic Autoantibodies. JCR: Journal of Clinical Rheumatology Publish Ahead of Print.
Crossref
Nerea Iniesta Arandia, Gerard Espinosa, Alfredo Guillén del Castillo, Carles Tolosa-Vilella, Dolores Colunga-Argüelles, Cristina González de Echávarri Pérez de Heredia, Gema M. Lledó, Luis Sáez Comet, Norberto Ortego-Centeno, José Antonio Vargas Hito, Manuel Rubio-Rivas, Mayka Freire, Juan José Ríos-Blanco, Mónica Rodríguez-Carballeira, Luis Trapiella-Martínez, Vicent Fonollosa-Pla & Carmen Pilar Simeón-Aznar. (2022) Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis. JCR: Journal of Clinical Rheumatology 28:1, pages e180-e188.
Crossref
Maria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, Jeska DeVries-Bouwstra, Montserrat-Ixchel Gonzalez-Perez, Jorge Rojas-Serrano, Eric Hachulla, Elisabetta Zanatta, Simone Barsotti, Federica Furini, Konstantinos Triantafyllias, Giuseppina Abignano, Marie-Elise Truchetet, Giacomo De Luca, Ellen De Langhe, Roger Hesselstrand, Francesca Ingegnoli, Eugenia Bertoldo, Vanessa Smith, Silvia Bellando-Randone, Hadi Poormoghim, Enrico Colombo, Angela Ceribelli, Alessio Furloni, Stefania Zingarelli, Ilaria Cavazzana, Franco Franceschini, Francesco Del Galdo, Christopher P Denton, Lorenzo Cavagna, Oliver Distler, Yannick Allanore & Paolo Airò. (2021) The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology 60:11, pages 5028-5041.
Crossref
Tatiana Nevskaya, Janet E. Pope, Matthew A. Turk, Jenny Shu, April Marquardt, Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Marco Matucci-Cerinic, Murray Baron, Christopher P. Denton & Sindhu R. Johnson. (2021) Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets. The Journal of Rheumatology 48:11, pages 1698-1717.
Crossref
Chloé Bost, Françoise Fortenfant, Antoine Blancher, Grégory Pugnet & Yves Renaudineau. (2021) Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis. Clinical Immunology 229, pages 108774.
Crossref
Ariane L. Herrick & Muditha Samaranayaka. 2021. Practical Management of Systemic Sclerosis in Clinical Practice. Practical Management of Systemic Sclerosis in Clinical Practice 255 269 .
Christopher P. Denton & Carol M. Black. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology 1183 1194 .
Yasuhito Hamaguchi, Masataka Kuwana & Kazuhiko Takehara. (2019) Performance evaluation of a line blot assay system for detection of anti‐PM‐Scl antibody in Japanese patients with systemic sclerosis. International Journal of Rheumatic Diseases 22:9, pages 1746-1751.
Crossref
Kosaku Murakami & Tsuneyo Mimori. (2019) Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders. Internal Medicine 58:1, pages 5-14.
Crossref
Danielle M. Tartar, Lorinda Chung & David F. Fiorentino. (2018) Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clinics in Dermatology 36:4, pages 508-524.
Crossref
Kevin Didier, Loïs Bolko, Delphine Giusti, Segolene Toquet, Ailsa Robbins, Frank Antonicelli & Amelie Servettaz. (2018) Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?. Frontiers in Immunology 9.
Crossref
Marvin J. Fritzler, Marie Hudson, May Y. Choi, Michael Mahler, Mianbo Wang, Chelsea Bentow, Jay Milo, Murray Baron, J. Pope, M. Baron, J. Markland, D. Robinson, N. Jones, N. Khalidi, P. Docherty, E. Kaminska, A. Masetto, E. Sutton, J.-P. Mathieu, M. Hudson, S. Ligier, T. Grodzicky, S. LeClercq, C. Thorne, G. Gyger, D. Smith, P.R. Fortin, M. Larché, M. Abu-Hakima, T.S. Rodriguez-Reyna, A.R. Cabral & M.J. Fritzler. (2018) Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Autoimmunity Reviews 17:3, pages 267-275.
Crossref
Carolina Mejia Otero, Shervin Assassi, Marie Hudson, Maureen D. Mayes, Rosa Estrada-Y-Martin, Claudia Pedroza, Tingting W. Mills, Jennifer Walker, Murray Baron, Wendy Stevens, Susanna M. Proudman, Mandana Nikpour, Sonal Mehra, Mianbo Wang & Marvin J. Fritzler. (2017) Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis. The Journal of Rheumatology 44:6, pages 799-805.
Crossref
David Bernal-Bello, Jaime García de Tena, Alfredo Guillén-del Castillo, Albert Selva-O'Callaghan, Eduardo L. Callejas-Moraga, Ana María Marín-Sánchez, Vicent Fonollosa-Pla & Carmen Pilar Simeón-Aznar. (2017) Novel risk factors related to cancer in scleroderma. Autoimmunity Reviews 16:5, pages 461-468.
Crossref
Cecília Varjú, Márta Péntek, Veronika Lóránd, Gabriella Nagy, Tünde Minier & László Czirják. (2016) Musculoskeletal Involvement in Systemic Sclerosis: An Unexplored Aspect of the Disease. Journal of Scleroderma and Related Disorders 2:1, pages 19-32.
Crossref
S. Hoa, M. Hudson, Y. Troyanov, S. Proudman, J. Walker, W. Stevens, M. Nikpour, S. Assassi, M.D. Mayes, M. Wang, M. Baron & M.J. Fritzler. (2016) Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects. Medicine 95:35, pages e4713.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.